Page 91

Febrero 2017

art ículo de revisi ón 227 Terapia simbiótica en pacientes infectados con VIH-1 - M. G. Feria et al cations for Management and Intervention. Curr Infect Dis Rep 2010; 12 (1): 19-27. 13. Doitsh G, Galloway N, Geng X, Yang Z, Monroe KM, Zepeda O, et al. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature 2014; 505 (7484): 509-14. 14. Marchetti G, Tincati C, Silvestri G. Microbial translocation in the pathogenesis of HIV infection and AIDS. Clin Microbiol Rev 2013; 26 (1): 2-18. 15. Khaitan A. Revisiting Immune Exhaustion During HIV Infection. Curr HIV/AIDS Rep 2012; 8 (1): 4-11. 16. Brenchley J, Price D, Douek D. HIV disease: fallout from a mucosal catastrophe? Nat Immunol 2006; 7 (3): 235-9. 17. Petroni A, Deluchi G, Larran G, Alonso B, Benetucci J. Viral load and disease progression as responsible for endothelial activation and/or injury in human immunodeficiency virus-1-infected patients. Blood Coagul Fibrinolysis 2003; 14 (1): 15-8. 18. Funderburg N, Zidar D, Shive C, Lioi A, Mudd J, Musselwhite L, et al. Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndrome. Blood 2012; 120 (23): 4599-608. 19. Estes J, Wietgrefe S, Schacker T, Southern P, Beilman G, Reilly C, et al. Simian Immunodeficiency Virus-Induced Lymphatic Tissue Fibrosis Is Mediated by Transforming Growth Factor b 1-Positive Regulatory T Cells and Begins in Early Infection. J Infect Dis 2007; 195 (1): 551-61. 20. Gareau M, Sherman P, Walker W. Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol 2010; 7 (9): 503-14. 21. Kechagia M, Basoulis D, Konstantopoulou S, Dimitriadi D, Gyftopoulou K, Skarmoutsou N, et al. Health Benefitd of Probiotics: A review. ISRN Nutr 2013; 2013: 1-7. 22. Sanders M, Akkermans L, Haller D, Hammerman C, Heimbach J, Hörmannsperger G, et al. Safety assessment of probiotics for human use. Gut Microbes 2010; 1 (3): 164-85. 23. Shoaf K, Mulvey G, Armstrong G, Hutkins R. Prebiotic Galactooligosaccharides Reduce Adherence of Enteropathogenic Escherichia coli to Tissue Culture Cells. Infect Immun 2006; 74 (12): 6920-8. 24. Commane D, Shortt C, Silvi S, Cresci A, Hughes R, Rowland I. Effects of fermentation products of pro- and prebiotics on trans-epithelial electrical resistance in an in vitro model of the colon. Nutr Cancer 2005; 51 (1): 102-9. 25. Guarner F. Prebiotics in inflammatory bowel diseases. Br J Nutr 2007; 98 Suppl 1: S85-9. 26. Vieira A, Teixeira M, Martins F. The role of probiotics and prebiotics in inducing gut immunity. Front Immunol 2013; 4 (445): 1-12. 27. Hardy H, Harris J, Lyon E, Beal J, Foey A. Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology. Nutrients 2013; 5 (6): 1869-912. 28. Dong H, Rowland I, Yaqoob P. Comparative effects of six probiotic strains on immune function in vitro. Br J Nutr 2011; 108 (1): 459-70. 29. Klatt N, Canary LA, Sun X, Vinton CL, Funderburg N, Morcock D, et al. Probiotic/prebiotic supplementation of antiretrovirals improves gastrointestinal immunity in SIV-infected macaques. J Clin Invest 2013; 123 (2): 903-7. 30. Konieczna P, Groeger D, Ziegler M, Frei R, Ferstl R, Shanahan F, et al. Bifidobacterium infantis 35624 administration induces Foxp3 T regulatory cells in human peripheral blood: potential role for myeloid and plasmacytoid dendritic cells. Gut 2012; 61: 354-66. 31. Groeger D, O’Mahony L, Murphy E, Bourke J, Dinan T, Kiely B, et al. Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut. Gut Microbes 2013; 4 (4): 325-39. 32. Resta-Lenert S, Barrett K. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 2003; 52: 988-97. 33. Wang L, Cao H, Liu L, Wang B, Walker W, Acra SA, et al. Activation of epidermal growth factor receptor mediates mucin production stimulated by p40, a Lactobacillus rhamnosus GG-derived protein. J Biol Chem 2014; 289 (29): 20234-44. 34. Rautava S, Arvilommi H, Isolauri E. Specific probiotics in enhancing maturation of IgA responses in formula fed infants. Pediatr Res 2006; 60 (2): 221-4. 35. Roselli M, Finamore A, Nuccitelli S, Carnevali P, Brigidi P, Vitali B, et al. Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of γδT and regulatory T cells of intestinal intraepithelial lymphocytes. Inflamm Bowel Dis 2009; 15 (10): 1526-36. 36. Möndel M, Schroeder B, Zimmermann K, Huber H, Nuding S, Beisner J, et al. Probiotic E. coli treatment mediates antimicrobial human beta-defensin synthesis and fecal excretion in humans. Mucosal Immunol 2009; 2 (2): 166-72. 37. Zschüttig A, Zimmermann K, Blom J, Goesmann A, Pöhlmann C, Gunzer F. Identification and characterization of microcin S, a new antibacterial peptide produced by probiotic Escherichia coli G3/10. PLoS One. 2012; 7 (3): 1-9. Rev Med Chile 2017; 145: 219-229


Febrero 2017
To see the actual publication please follow the link above